...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: OTC Short Interest up 4.08% to 720,060 shr as of 12/31/21
Reply New Message
Prev Message Back To Forum Threaded View Next Message
SHORT INTEREST
DATE
SHORT INTEREST
% CHANGE
AVG. DAILY SHARE VOL
DAYS TO COVER
SPLIT
NEW ISSUE
12/31/2021 720,060 4.08 45,779 15.73 No No
12/15/2021 691,811 4.04 25,309 27.33 No No
11/30/2021 664,922 3.55 76,697 8.67 No No
11/15/2021 642,099 6.67 96,238 6.67 No No
10/29/2021 601,975 60.21 27,190 22.14 No No
10/15/2021 375,738 4.46 27,139 13.84 No No
09/30/2021 359,691 2.95 26,933 13.36 No No
09/15/2021 349,382 -5.18 37,015 9.44 No No
08/31/2021 368,479 3.37 17,636 20.89 No No
08/13/2021 356,474 1.09 18,718 19.04 No No
1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply